Cegedim SA (EPA:ALCGM)
France · Delayed Price · Currency is EUR 10.50
+0.40 (3.96%)
Aug 3, 2026, 12:06 PM CET
Cegedim Market Cap
Cegedim has a market cap or net worth of €138.68 million as of August 3, 2026. Its market cap has decreased by -7.23% in one year.
Market Cap
138.68M
Enterprise Value
387.98M
Revenue
649.17M
Ranking
n/a
PE Ratio
14.78
Stock Price
€10.50
ChartMarket Cap Chart
Since November 7, 1995, Cegedim's market cap has increased from 113.85M to 138.68M, an increase of 21.81%. That is a compound annual growth rate of 0.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 138.68M | -25.66% |
| Dec 31, 2025 | 186.56M | 6.71% |
| Dec 31, 2024 | 174.83M | -28.22% |
| Dec 29, 2023 | 243.57M | 22.47% |
| Dec 30, 2022 | 198.89M | -39.93% |
| Dec 31, 2021 | 331.11M | -6.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 89.22B |
| EssilorLuxottica Société anonyme | 75.40B |
| Sartorius Stedim Biotech | 16.22B |
| Ipsen | 13.71B |
| Transgene | 194.73M |
| Cellectis | 179.18M |
| Bastide Le Confort Médical | 173.44M |
| Median Technologies | 157.81M |